Na Liu

机构：Hebei Medical University, Second Hospital of Hebei Medical University, Hainan General Hospital, Liaoning Cancer Hospital & Institute, Hainan Medical University, China Medical University · ORCID：0000-0002-4405-4583

发表论文 22 篇 · 总被引 344 次 · h-index 11

代表论文

• Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes (2017 · Genes Chromosomes and Cancer · 被引 70)
• SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS (2020 · Blood · 被引 50)
• Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia (2022 · Cell Research · 被引 42)
• Prognostic significance of FLT3-ITD in pediatric acute myeloid leukemia: a meta-analysis of cohort studies (2016 · Molecular and Cellular Biochemistry · 被引 33)
• Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status (2015 · Leukemia Research · 被引 26)
• Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis (2018 · Proceedings of the National Academy of Sciences · 被引 24)